Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
China
· Delayed Price · Currency is CNY 34.11
-0.28 (-0.81%)
Mar 11, 2026, 12:44 PM CST
SHE:002864 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 120.51 | 120.27 | 110.43 | 101.16 | 93.17 | 79.12 | Upgrade
|
| Depreciation & Amortization | 32.95 | 32.95 | 31.05 | 18.31 | 16.85 | 14.45 | Upgrade
|
| Other Amortization | 0.5 | 0.5 | 0.19 | 0.02 | 0.08 | 0.07 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | -0.17 | - | - | -0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.62 | 2.62 | 5.7 | 0.08 | 0 | 0.19 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.63 | -0.63 | 1.56 | 0.11 | - | -5.62 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | 8.36 | 4.61 | 3.67 | Upgrade
|
| Other Operating Activities | -38.21 | 1.21 | 5.6 | 12.25 | 5.89 | 6.25 | Upgrade
|
| Change in Accounts Receivable | -12.48 | -12.48 | -46.14 | -94.42 | -56.67 | -38.96 | Upgrade
|
| Change in Inventory | -18.21 | -18.21 | 4.97 | -28.1 | -0.46 | 2.06 | Upgrade
|
| Change in Accounts Payable | 29.16 | 29.16 | -14.63 | 104.67 | 55.81 | 33.14 | Upgrade
|
| Change in Other Net Operating Assets | -0.89 | -0.89 | 1.96 | 1.69 | - | - | Upgrade
|
| Operating Cash Flow | 117.4 | 156.59 | 104.05 | 125.36 | 116.04 | 92.24 | Upgrade
|
| Operating Cash Flow Growth | -21.80% | 50.50% | -17.00% | 8.04% | 25.80% | 35.87% | Upgrade
|
| Capital Expenditures | -72.27 | -82.05 | -62.51 | -55.84 | -80.68 | -71.18 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.27 | 0 | 0.15 | 0.03 | 0.03 | 0.18 | Upgrade
|
| Cash Acquisitions | - | -23.49 | - | - | -5.1 | -1.91 | Upgrade
|
| Divestitures | 0.03 | 0.03 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | 2.39 | -10 | - | 234 | Upgrade
|
| Other Investing Activities | - | 2 | -2.44 | 28.24 | - | 8.75 | Upgrade
|
| Investing Cash Flow | -71.98 | -103.51 | -62.41 | -37.57 | -85.75 | 169.84 | Upgrade
|
| Long-Term Debt Issued | - | 150 | 134.17 | 431.69 | 50.74 | 108 | Upgrade
|
| Total Debt Issued | 50 | 150 | 134.17 | 431.69 | 50.74 | 108 | Upgrade
|
| Long-Term Debt Repaid | - | -100.9 | -169.89 | -108.93 | -14.17 | -70.64 | Upgrade
|
| Total Debt Repaid | -51.4 | -100.9 | -169.89 | -108.93 | -14.17 | -70.64 | Upgrade
|
| Net Debt Issued (Repaid) | -1.4 | 49.1 | -35.73 | 322.77 | 36.57 | 37.36 | Upgrade
|
| Issuance of Common Stock | - | - | 297.25 | 15.07 | - | - | Upgrade
|
| Repurchase of Common Stock | -10.3 | -10.3 | -0.06 | - | -10.1 | -20.05 | Upgrade
|
| Common Dividends Paid | -42.89 | -24.52 | -24.3 | -21.09 | -17.89 | -16.52 | Upgrade
|
| Other Financing Activities | 9.6 | - | -0.24 | -0.4 | -1.56 | 1.45 | Upgrade
|
| Financing Cash Flow | -44.99 | 14.28 | 236.93 | 316.35 | 7.01 | 2.24 | Upgrade
|
| Net Cash Flow | 0.44 | 67.36 | 278.57 | 404.14 | 37.3 | 264.32 | Upgrade
|
| Free Cash Flow | 45.13 | 74.54 | 41.53 | 69.53 | 35.36 | 21.06 | Upgrade
|
| Free Cash Flow Growth | -41.04% | 79.47% | -40.26% | 96.63% | 67.91% | -38.67% | Upgrade
|
| Free Cash Flow Margin | 4.11% | 7.65% | 4.23% | 7.14% | 3.98% | 3.14% | Upgrade
|
| Free Cash Flow Per Share | 0.43 | 0.71 | 0.42 | 0.80 | 0.41 | 0.24 | Upgrade
|
| Cash Income Tax Paid | 99.46 | 98.83 | 95.65 | 93.22 | 84.74 | 71.28 | Upgrade
|
| Levered Free Cash Flow | -33.25 | 4.53 | -2.9 | 72.68 | -17.87 | -89.11 | Upgrade
|
| Unlevered Free Cash Flow | -32.44 | 5.5 | 0.92 | 81.38 | -15.68 | -87.33 | Upgrade
|
| Change in Working Capital | -0.35 | -0.35 | -50.31 | -14.94 | -4.57 | -5.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.